HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (21) Citing Articles via Google Scholar Google Scholar Articles by Bland, R Articles by Williams, G R Search for Related Content PubMed PubMed Citation Articles by Bland, R Articles by Williams, G R

3,5,3'-Tri-iodothyronine (T₃), 1,25(OH)₂-vitamin D₃ (D₃) and retinoids activate related nuclear receptors which interact by heterodimerisation to regulate gene expression. Actions of each hormone are discrete and may be specified by changes in the relative concentrations of their receptors (T₃R, vitamin D receptor (VDR), retinoic acid receptor (RAR), retinoid X receptor (RXR)). T₃, D₃ and retinoids are essential for skeletal development and maintenance and we have previously shown complex interactions amongst their signalling pathways in osteosarcoma cells. In these studies we demonstrate that similar T₃R, VDR, RAR and RXR proteins are co-expressed in both osteoblast lineage cell primary cultures and osteosarcoma cells by Western blotting. We investigated whether hormone interactions in bone result from changes in receptor stoichiometry. Cells were treated with combinations of T₃, D₃, 9-cis retinoic acid (9-cis RA) and all-trans retinoic acid (RA) that are known from previous studies to produce complex cell specific responses. No alteration in expression of any receptor protein was seen in response to any hormone combination in three phenotypically distinct osteosarcoma cell lines. Thus, in contrast to studies of overexpressed receptors in vitro, changes in the physiological concentrations of endogenous T₃R, VDR, RAR and RXR do not specify discrete hormone actions in osteoblastic cells. Other unidentified factors are likely to modulate hormone action in these bone cells.

Journal of Endocrinology (1997) 154, 63–74

This article has been cited by other articles:

				A Scarlett, M P Parsons, P L Hanson, K K Sidhu, T P Milligan, and J M Burrin Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin {alpha}V{beta}3 J. Endocrinol., March 1, 2008; 196(3): 509 - 517. [Abstract] [Full Text] [PDF]

				L. Schneider, C. El-Yazidi, A. Dace, M. Maraninchi, R. Planells, A. Margotat, and J. Torresani Expression of the 1,25-(OH)2 vitamin D3 receptor gene during the differentiation of mouse Ob17 preadipocytes and cross talk with the thyroid hormone receptor signalling pathway J. Mol. Endocrinol., February 1, 2005; 34(1): 221 - 235. [Abstract] [Full Text] [PDF]

				K. Prufer, C. Schroder, K. Hegyi, and J. Barsony Degradation of RXRs Influences Sensitivity of Rat Osteosarcoma Cells to the Antiproliferative Effects of Calcitriol Mol. Endocrinol., May 1, 2002; 16(5): 961 - 976. [Abstract] [Full Text] [PDF]

				A. Siddiqi, M. P. Parsons, J. L. Lewis, J. P. Monson, G. R. Williams, and J. M. Burrin TR Expression and Function in Human Bone Marrow Stromal and Osteoblast-Like Cells J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 906 - 914. [Abstract] [Full Text] [PDF]

				H. Robson, T. Siebler, D. A. Stevens, S. M. Shalet, and G. R. Williams Thyroid Hormone Acts Directly on Growth Plate Chondrocytes to Promote Hypertrophic Differentiation and Inhibit Clonal Expansion and Cell Proliferation Endocrinology, October 1, 2000; 141(10): 3887 - 3897. [Abstract] [Full Text] [PDF]

				M. Milne, M.-I. Kang, J. M. Quail, and D. T. Baran Thyroid Hormone Excess Increases Insulin-Like Growth Factor I Transcripts in Bone Marrow Cell Cultures: Divergent Effects on Vertebral and Femoral Cell Cultures Endocrinology, May 1, 1998; 139(5): 2527 - 2534. [Abstract] [Full Text] [PDF]